n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid has been researched along with edetic acid in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (16.28) | 18.7374 |
1990's | 12 (27.91) | 18.2507 |
2000's | 13 (30.23) | 29.6817 |
2010's | 9 (20.93) | 24.3611 |
2020's | 2 (4.65) | 2.80 |
Authors | Studies |
---|---|
Hauser, H; Hull, WE; Kalthoff, H; Klivényi, G; Maier-Borst, W; Matys, R; Matzku, S; Schmiegel, WH; Schuhmacher, J | 1 |
Chitambar, CR; Lundberg, JH | 1 |
Grady, RW; Hershko, C | 2 |
Grady, RW; Hershko, C; Spira, DT; Theanacho, EN; Yinnon, AM | 1 |
Bautovich, GJ; Hunt, FC; Maddalena, DJ; Wilson, JG | 1 |
Hunt, FC | 1 |
Chew, BP; Tanaka, TS; Tjoelker, LW | 1 |
Cerny, EA; Lau, EH; Rahman, YE; Wright, BJ | 1 |
Carnes, BA; Cerny, EA; Lau, EH; Rahman, YE | 1 |
Grady, RW; Hershko, C; Link, G | 1 |
Giardina, PJ; Grady, RW; Hilgartner, MW; Salbe, AD | 1 |
Burnel, D; Graff, L; Muller, G | 1 |
Hider, RC; Tilbrook, GS | 1 |
Bergeron, RJ; Brittenham, GM; Wiegand, J | 3 |
Hershko, C; Konijn, AM; Link, G | 1 |
Donnelly, H; Faller, B; Fox, R; Lowther, N; Sergejew, T; Tomlinson, B | 1 |
Faller, B; Sergejew, T; Spanka, C; Tschinke, V | 1 |
Andrews, GK; Bittel, D; Hider, RC | 1 |
Hoshino, H; Krokhin, OV; Kuzina, OV; Shpigun, OA; Yotsuyanagi, T | 1 |
Hoshino, H; Krokhin, OV; Shpigun, OA; Yotsuyanagi, T | 1 |
Afeworki, M; Brechbiel, MW; DeGraff, W; Krishna, MC; Mitchell, JB; Samuni, AM; Stein, W; Yordanov, AT | 1 |
Cook, J | 1 |
Clarke, JJ; Dunkel, VC; San, RH; Seifried, HE; Whittaker, P | 1 |
Cunningham, S; Hillard, CJ; Kalivendi, SV; Kalyanaraman, B; Kotamraju, S; Shang, T | 1 |
Bi, HP; Wang, JL; Yang, BS | 1 |
Wang, Z; Yang, B | 1 |
Incarvito, CD; Tinoco, AD; Valentine, AM | 1 |
Jarrett, SG; Liang, LP; Patel, M | 1 |
Hernández, D; López-Rayo, S; Lucena, JJ | 1 |
Cook, JA; DeGraff, W; Fabre, KM; Krishna, MC; Mitchell, JB; Saito, K; Sowers, AL; Thetford, A | 1 |
Incarvito, CD; Saghatelian, A; Thomas, HR; Tinoco, AD; Valentine, AM | 1 |
Abboud, KA; Sloan, KB; Thiele, NA | 1 |
Sloan, KB; Thiele, NA | 1 |
Bin, LM; Bugter, MH; Weng, L | 1 |
Campbell, A; Kumar, D; Langton, T; McCarthy, M | 1 |
Hubble, D; Robins, P | 1 |
Campbell, A; Francis, R; McCarthy, M; Tang, C; Watts, J | 1 |
Klika, KD; Kopka, K; Litau, G; Makarem, A; Remde, Y | 1 |
Can, C; Komek, H | 1 |
Knutson, M; Lavin, SR; Livingston, S; Sullivan, KE; Valdes, EV; Warren, LK | 1 |
4 review(s) available for n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and edetic acid
Article | Year |
---|---|
An evaluation of the potential of HBED as an orally effective iron-chelating drug.
Topics: Administration, Oral; Animals; Chelation Therapy; Chemical Phenomena; Chemistry; Edetic Acid; Female; Iron Chelating Agents; Male; Rats | 1990 |
HBED: a potential oral iron chelator.
Topics: Administration, Oral; Animals; Blood Transfusion; Chelating Agents; Edetic Acid; Iron; Rats; Rats, Inbred Strains | 1990 |
Iron chelators for clinical use.
Topics: Biological Transport; Deferoxamine; Drug Delivery Systems; Edetic Acid; Ferric Compounds; Free Radical Scavengers; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Molecular Weight; Oxidation-Reduction; Pentetic Acid; Razoxane; Solubility; Structure-Activity Relationship; Tissue Distribution | 1998 |
Iron chelators for thalassaemia.
Topics: Administration, Oral; Aza Compounds; Chelating Agents; Deferiprone; Deferoxamine; Edetic Acid; Humans; Iron; Iron Chelating Agents; Iron Overload; Long-Term Care; Pyridones; Thalassemia | 1998 |
3 trial(s) available for n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and edetic acid
Article | Year |
---|---|
Results from a phase I clinical trial of HBED.
Topics: Adolescent; Adult; beta-Thalassemia; Chelating Agents; Deferoxamine; Edetic Acid; Female; Humans; Iron; Male; Transfusion Reaction | 1994 |
A Multicenter Prospective Clinical Trial of
Topics: Aged; Aged, 80 and over; Antigens, Surface; Bone and Bones; Carcinoma; Cross-Sectional Studies; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Kallikreins; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Pelvis; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 2019 |
Safety and efficacy of a novel iron chelator (HBED; (N,N'-Di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid)) in equine (Equus caballus) as a model for black rhinoceros (Diceros bicornis).
Topics: Acetates; Animals; Edetic Acid; Ethylenediamines; Horse Diseases; Horses; Iron; Iron Chelating Agents; Iron Overload; Perissodactyla | 2022 |
36 other study(ies) available for n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and edetic acid
Article | Year |
---|---|
A bifunctional HBED-derivative for labeling of antibodies with 67Ga, 111In and 59Fe. Comparative biodistribution with 111In-DPTA and 131I-labeled antibodies in mice bearing antibody internalizing and non-internalizing tumors.
Topics: Animals; Antibodies, Monoclonal; Edetic Acid; Gallium Radioisotopes; Indium Radioisotopes; Iodine Radioisotopes; Iron Radioisotopes; Isotope Labeling; Magnetic Resonance Spectroscopy; Mice; Neoplasms, Experimental; Pentetic Acid | 1992 |
Interaction of gallium nitrate with fludarabine and iron chelators: effects on the proliferation of human leukemic HL60 cells.
Topics: Antineoplastic Agents; Cell Division; Deferoxamine; Drug Synergism; Edetic Acid; Gallium; Humans; Iron; Iron Chelating Agents; Leukemia, Promyelocytic, Acute; Tumor Cells, Cultured; Vidarabine Phosphate | 1990 |
Antimalarial effect of HBED and other phenolic and catecholic iron chelators.
Topics: Animals; Catechols; Chelating Agents; Edetic Acid; Erythrocytes; Female; Malaria; Phenols; Plasmodium berghei; Rats; Rats, Inbred Strains | 1989 |
Phenolic aminocarboxylate chelates of 99mTc as hepatobiliary agents.
Topics: Animals; Edetic Acid; Ethylenediamines; Female; Gallbladder; Liver; Metabolic Clearance Rate; Radionuclide Imaging; Rats; Rats, Inbred Strains; Technetium | 1986 |
Potential radiopharmaceuticals for the diagnosis of biliary atresia and neonatal hepatitis: EHPG and HBED chelates of 67Ga and 111In.
Topics: Animals; Biliary Atresia; Chelating Agents; Edetic Acid; Ethylenediamines; Female; Gallium Radioisotopes; Hepatitis; Humans; Indium Radioisotopes; Infant, Newborn; Male; Mice; Mice, Inbred BALB C; Rabbits; Radionuclide Imaging | 1988 |
In vitro growth inhibition of mastitis causing bacteria by phenolics and metal chelators.
Topics: Animals; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Cattle; Chelating Agents; Deferoxamine; Edetic Acid; Escherichia coli; Ethylenediamines; Female; Hydroquinones; In Vitro Techniques; Klebsiella pneumoniae; Mastitis, Bovine; Pentetic Acid; Phenols; Staphylococcus aureus; Streptococcus agalactiae | 1985 |
Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
Topics: Animals; Bile; Bile Canaliculi; Chelating Agents; Deferoxamine; Edetic Acid; Feces; Female; Iron; Kupffer Cells; Liposomes; Liver; Mice; Microscopy, Electron; Mononuclear Phagocyte System; Tissue Distribution | 1983 |
Enhanced iron removal from liver parenchymal cells in experimental iron overload: liposome encapsulation of HBED and phenobarbital administration.
Topics: Animals; Deferoxamine; Edetic Acid; Feces; Ferritins; Iron; Liposomes; Liver; Mice; Phenobarbital | 1983 |
Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters.
Topics: Administration, Oral; Animals; Deferoxamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Edetic Acid; Ethylenediamines; Female; Infusions, Parenteral; Iron Chelating Agents; Iron Radioisotopes; Rats; Rats, Inbred Strains; Transfusion Reaction | 1984 |
In vitro and in vivo evaluation of potential aluminum chelators.
Topics: Aluminum; Animals; Cadmium; Calcium; Chelating Agents; Citrates; Citric Acid; Copper; Edetic Acid; Ethylenediamines; In Vitro Techniques; Injections, Intraperitoneal; Iron; Male; Polarography; Rats; Solubility; Temperature; Zinc | 1995 |
HBED: A potential alternative to deferoxamine for iron-chelating therapy.
Topics: Animals; Antidotes; Chelating Agents; Deferoxamine; Edetic Acid; Haplorhini; Iron Overload; Male; Rats; Rats, Sprague-Dawley; Transfusion Reaction | 1998 |
Caco-2 cell permeability of a new (hydroxybenzyl)ethylenediamine oral iron chelator: correlation with physicochemical properties and oral activity.
Topics: Administration, Oral; Animals; Caco-2 Cells; Callithrix; Cell Membrane Permeability; Edetic Acid; Humans; Iron; Iron Chelating Agents | 1998 |
HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapy.
Topics: Administration, Oral; Animals; Cebus; Deferoxamine; Edetic Acid; Injections, Intravenous; Injections, Subcutaneous; Iron; Iron Chelating Agents; Iron Overload; Iron-Dextran Complex; Male; Rats; Rats, Sprague-Dawley | 1999 |
Improving the oral bioavailability of the iron chelator HBED by breaking the symmetry of the intramolecular H-bond network.
Topics: Administration, Oral; Animals; Biological Availability; Callithrix; Edetic Acid; Feces; Hydrogen Bonding; Iron; Iron Chelating Agents; Molecular Conformation; Monte Carlo Method; Solubility; Solvents; Structure-Activity Relationship | 2000 |
Competition between iron(III)-selective chelators and zinc-finger domains for zinc(II).
Topics: Animals; Binding, Competitive; Deferiprone; DNA-Binding Proteins; Edetic Acid; Iron; Iron Chelating Agents; Mice; Pyridones; Recombinant Proteins; Transcription Factor MTF-1; Transcription Factors; Zinc; Zinc Fingers | 1999 |
Potential of ethylenediaminedi(o-hydroxyphenylacetic acid) and N,N'-bis(hydroxybenzyl)ethylenediamine-N,N'-diacetic acid for the determination of metal ions by capillary electrophoresis.
Topics: Cations; Edetic Acid; Electrophoresis, Capillary; Ethylenediamines; Metals; Oxidation-Reduction | 2000 |
Separation selectivity of anionic metal complexes of N,N'-bis(hydroxybenzyl)ethylenediamine-N,N'-diacetic acid in ion and ion electrokinetic chromatography.
Topics: Anions; Chromatography, Micellar Electrokinetic Capillary; Edetic Acid; Hydrogen-Ion Concentration; Metals; Sensitivity and Specificity | 2000 |
Multifunctional antioxidant activity of HBED iron chelator.
Topics: Animals; Antioxidants; Benzothiazoles; Cell Death; Cell Line; Cell Survival; Chromans; Cricetinae; Cricetulus; Cyclic N-Oxides; Cytoprotection; Edetic Acid; Electron Spin Resonance Spectroscopy; Hydrogen; Hydrogen Peroxide; Hydroxyl Radical; Iron Chelating Agents; Oxidation-Reduction; Oxygen; Phenols; Spectrophotometry; Spin Labels; Sulfonic Acids; Superoxides; tert-Butylhydroperoxide | 2001 |
Radiation sensitization of mammalian cells by metal chelators.
Topics: Animals; Cell Cycle; Chelating Agents; Colony-Forming Units Assay; Cricetinae; Cricetulus; Deferiprone; Deferoxamine; DNA Replication; Edetic Acid; Fibroblasts; Genes, p53; Humans; Iron Chelating Agents; Lung; Lung Neoplasms; Mimosine; Pyridones; Radiation-Sensitizing Agents; S Phase; Tumor Cells, Cultured | 2001 |
Genotoxicity of iron chelators in L5178Y mouse lymphoma cells.
Topics: Animals; Deferiprone; Edetic Acid; Iron Chelating Agents; Lymphoma; Mice; Mutagenicity Tests; Phenanthrolines; Pyridones; Razoxane; Tumor Cells, Cultured | 2001 |
HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning.
Topics: Acute Disease; Animals; Blood Pressure; Cebus; Chronic Disease; Deferoxamine; Disease Models, Animal; Dogs; Drug Administration Routes; Drug Evaluation, Preclinical; Edetic Acid; Heart Rate; Iron; Iron Chelating Agents; Iron Overload; Male; Poisoning; Rats; Rats, Sprague-Dawley; Therapeutic Equivalency | 2002 |
1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide.
Topics: 1-Methyl-4-phenylpyridinium; Aconitate Hydratase; Animals; Antioxidants; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Deferoxamine; Edetic Acid; Female; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Hydrogen Peroxide; Iron; Iron Chelating Agents; Male; Metalloporphyrins; Mitochondria; NADH, NADPH Oxidoreductases; Neurons; Oxidants; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Receptors, Transferrin; Staining and Labeling; Transferrin | 2003 |
[Determination on conditional equilibrium constants of the complexes of Gd(III) and Yb(III) with HBED by UV difference spectra].
Topics: Algorithms; Edetic Acid; Gadolinium; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Molecular Structure; Organometallic Compounds; Spectrophotometry, Ultraviolet; Temperature; Thermodynamics; Ytterbium | 2005 |
UV and fluorescence spectral changes induced by neodymium binding of N,N'-ethylenebis[2-(o-hydroxyphenolic)glycine] and N,N'-di(2-hydroxybenzyl)ethylenediamine-N,N' diacetic acid.
Topics: Edetic Acid; Ethylenediamines; Fluorescence; Iron Chelating Agents; Neodymium; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Ultraviolet Rays | 2006 |
Calorimetric, spectroscopic, and model studies provide insight into the transport of Ti(IV) by human serum transferrin.
Topics: Binding Sites; Calorimetry; Chelating Agents; Crystallography, X-Ray; Edetic Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Organometallic Compounds; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Titanium; Transferrin | 2007 |
Chelation of mitochondrial iron prevents seizure-induced mitochondrial dysfunction and neuronal injury.
Topics: Analysis of Variance; Animals; Behavior, Animal; Bleomycin; Chelating Agents; Colorimetry; Disease Models, Animal; DNA, Mitochondrial; Edetic Acid; Fluoresceins; Glutathione; Glutathione Disulfide; Hippocampus; Iron; Kainic Acid; Male; Mitochondrial Diseases; Organic Chemicals; Rats; Rats, Sprague-Dawley; Status Epilepticus; Subcellular Fractions; Time Factors | 2008 |
Chemical evaluation of HBED/Fe(3+) and the novel HJB/Fe(3+) chelates as fertilizers to alleviate iron chlorosis.
Topics: Adsorption; Calcium; Copper; Drug Stability; Edetic Acid; Ferric Compounds; Fertilizers; Iron; Iron Chelating Agents; Magnesium; Models, Molecular; Plant Diseases; Soil; Solubility; Solutions | 2009 |
The effects of resveratrol and selected metabolites on the radiation and antioxidant response.
Topics: Animals; Antioxidants; Cell Cycle; Cell Survival; Dose-Response Relationship, Drug; Edetic Acid; Female; Fibroblasts; Humans; Hydrogen Peroxide; Mice; Mice, Inbred C3H; Oxidative Stress; Phenols; Quinones; Radiation-Protective Agents; Resveratrol; Stilbenes; tert-Butylhydroperoxide; Whole-Body Irradiation | 2011 |
Cytotoxicity of a Ti(IV) compound is independent of serum proteins.
Topics: Blood Proteins; Cell Death; Cell Line, Tumor; Chelating Agents; Chromatography, Liquid; Crystallography, X-Ray; Dimethylformamide; Drug Screening Assays, Antitumor; Edetic Acid; Humans; Hydrogen-Ion Concentration; Mass Spectrometry; Potentiometry; Serum Albumin; Spectrophotometry; Titanium; Transferrin | 2012 |
Novel double prodrugs of the iron chelator N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED): Synthesis, characterization, and investigation of activation by chemical hydrolysis and oxidation.
Topics: Boronic Acids; Cell Membrane Permeability; Copper; Edetic Acid; Hydrolysis; Iron; Iron Chelating Agents; Oxidation-Reduction; Prodrugs; Solubility; Water | 2016 |
A Double Prodrug with Improved Membrane Permeability over the Parent Chelator HBED Provides Superior Cytoprotection against Hydrogen Peroxide.
Topics: Boronic Acids; Cell Line; Cell Membrane Permeability; Diffusion; Edetic Acid; Humans; Hydrogen Peroxide; Hydrolysis; Iron Chelating Agents; Oxidation-Reduction; Prodrugs; Protective Agents; Solubility | 2016 |
Effectiveness of FeEDDHA, FeEDDHMA, and FeHBED in Preventing Iron-Deficiency Chlorosis in Soybean.
Topics: Chlorophyll; Edetic Acid; Ethylenediamines; Fertilizers; Glycine max; Iron; Iron Chelating Agents; Manganese; Plant Diseases; Soil; Spain | 2016 |
Comparison of PSMA-HBED and PSMA-I&T as diagnostic agents in prostate carcinoma.
Topics: Aged; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2017 |
RE: Uptake in sympathetic ganglia on 68Ga-PSMA-HBED PET/CT: A potential pitfall in scan interpretation.
Topics: Edetic Acid; Ganglia, Sympathetic; Positron Emission Tomography Computed Tomography | 2018 |
HBED-NN: A Bifunctional Chelator for Constructing Radiopharmaceuticals.
Topics: Chelating Agents; Edetic Acid; Gallium; Humans; Molecular Structure; Neoplasms; Radiopharmaceuticals | 2019 |
Contribution of 5th minute and 2nd hour images to standard imaging in (
Topics: Aged; Aged, 80 and over; Antigens, Surface; Bone Neoplasms; Edetic Acid; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Lymph Nodes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2020 |